相关实验视频

Updated: Jul 25, 2025

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

载体剂对喷雾干燥封装二氧化基因粉末的质量参数的影响以及过程参数的优化

Prajya Arya¹, Pradyuman Kumar¹

¹Department of Food Engineering and Technology, Sant Longowal Institute of Engineering and Technology, Sangrur 148106, Punjab, India.

Foods (Basel, Switzerland)

|June 28, 2023

概括

喷雾干燥封装的二氧化原蛋白 (EDP) 与麦芽素 (MD) 或乳清蛋白缩物 (WPC) 改善了其性能. 优化的条件产生了高封装效率和抗氧化活性,使EDP成为健康益处的有希望成分.

科学领域:

食品科学食品科学食品科学
营养保健品营养保健品
生物材料是一种生物材料.

背景情况:

格力克种子含有迪奥斯基宁,一种具有健康益处的类固醇肥素.
天然迪奥斯基宁的苦味和低消费量限制了它的健康应用.
封装是一种提高迪奥斯基宁可口性和生物利用性的策略.

研究的目的:

优化喷雾干燥过程,使用马尔托德 (MD) 和乳清蛋白缩物 (WPC) 封装迪奥斯基宁.
评估喷雾干燥条件对优化封装迪奥斯基宁粉末 (EDP) 性能的影响.
评估EDP作为食品矩阵中的功能成分的适用性.

主要方法:

用MD和WPC作为墙壁材料使用喷雾干燥来封装迪奥斯基宁.
喷雾干燥参数 (入口空气温度,料流量,载体度) 被优化.
分析了关键参数,包括产量,封装效率,水分含量,抗氧化活性,湿度和可溶性.
微图和衍光图被用来描述优化的EDP样本.

主要成果:

最佳封装条件被确定为170°C的进气温度,500毫升/小时的料流量,以及MD和WPC的20%载体剂度.
乳清蛋白缩 diosgenin 粉末 (WPC-EDP) 显示出更高的产量 (82.25%),封装效率 (88.60%),抗氧化活性 (53.95%),和高度 (12.64%).
马尔托德克斯特林封装的二氧化物粉 (MD-EDP) 具有较高的溶解率 (96.64%) 和较低的水分含量 (2.58%).
无论是MD-EDP还是WPC-EDP,都表现出无形性质和可接受的粉末特性.

结论:

优化的喷雾干燥有效地掩盖了diosgenin的苦味,并改善了其粉末特性.
使用WPC和MD生产的EDP证明了其作为一种功能成分的潜力,可以在各种食品中提供健康益处.
该研究强调了EDP适合纳入食品矩阵作为健康促进化合物的输送工具的适用性.

关键词:

在 diosgenin 的基础上.优化的优化优化优化.粉末形态学粉末形态学过程参数过程参数喷雾干燥喷雾干燥

更多相关视频

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

相关概念视频

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...